The decreased spexin levels were observed in type 2 DM, and further more decreased in type 2 DM with CVD patients compared to controls indicatingthat spexin levels could be served as an early prediction of obesity-induced T2DM with CVD risk. The gene discussed is SPX; the disease is type 2 diabetes mellitus.